Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT05065203
Other study ID # 60762
Secondary ID
Status Completed
Phase
First received
Last updated
Start date October 21, 2021
Est. completion date January 31, 2023

Study information

Verified date June 2023
Source Stanford University
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

Sleep is critical to mental and physical health following childbirth. However, patients who are hospitalized for labor and delivery may be admitted for days with significant impacts on sleep levels. Little is known about sleep and activity levels in inpatients during nighttime and daytime following childbirth and how this may affect their mental and physical health and wellbeing. If abnormalities are identified, targeted interventions may be possible to optimize recovery following delivery.


Recruitment information / eligibility

Status Completed
Enrollment 78
Est. completion date January 31, 2023
Est. primary completion date September 30, 2022
Accepts healthy volunteers No
Gender Female
Age group 18 Years to 60 Years
Eligibility Inclusion Criteria: - over 18 years old - live pregnancy - Single or multiple gestation - all gestational ages Exclusion Criteria: - Weekend delivery - admitted to critical care - unable to speak or understand English - known sleeping disorder - opioid requirement prior to admission - long term steroids use - significant autoimmune or neurological disease - significant psychiatric or neurodevelopment disorder

Study Design


Related Conditions & MeSH terms


Intervention

Procedure:
planned or unplanned Cesarean, operative, or non operative delivery
All types of delivery

Locations

Country Name City State
United States Lucile Packard Children's Hospital Stanford California

Sponsors (1)

Lead Sponsor Collaborator
Stanford University

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Assessment of inpatient postpartum sleep using actigraphy Participants will wear an acitgraphy watch during their inpatient stay to measure sleep. During inpatient stay (up to 7 days)
Secondary Association between actigraphy data with inpatient and outpatient postpartum Patient Reported Outcome Measures (PROMs) Measurement of postpartum actigraphy data to associate with patient reported outcome measures (PROM) (ObsQoR-10, Edinburgh Postpartum Depression Score, WHO-QOL-BREF and Bergen Insomnia Scale Score) given by face to face then remote interview Day 1-7, 6 and 12 weeks
Secondary Association between inpatient actigraphy data and patient demographic, medical, obstetric, psychiatric, neonatal and anesthetic factors Participants will wear an acitgraphy watch during their inpatient stay to measure physical activity and sleep. During inpatient stay and outpatient follow up (up to 7 days)
Secondary Association between outpatient sleep data with patient demographic, medical, obstetric, psychiatric, neonatal and anesthetic factors Participants will be interviewed at 6 and 12 weeks with PROM questions and sleep diaries to assess for association with demographic, medical obstetric, psychiatric neonatal and anaesthetic factors. 6 and 12 weeks
Secondary Association between objective (artigraphy) and subjective sleep assessment using diaries and PROMs Participants will wear an acitgraphy watch during their inpatient stay to measure physical activity and sleep. PROM survey data during inpatient day 1-7 and outpatient 6- 12 week interview. Day 1-7, 6 and 12 weeks
Secondary Determine population norms of objective and subjective sleep measures in the postpartum population. Participants will wear an acitgraphy watch during their inpatient stay to measure physical activity and sleep. PROM survey data during inpatient day 1-7 and outpatient 6 and 12 week interview. Day 1-7, 6 and 12 weeks
Secondary Association between inpatient sleep and physical activity, PROMs and peripartum course with longer term outpatient sleep measures Participants will wear an acitgraphy watch during their inpatient stay to measure physical activity and sleep. PROM survey data during inpatient day 1-7 and outpatient 6 and 12 week interview. Day 1-7, 6 and 12 weeks
See also
  Status Clinical Trial Phase
Completed NCT04044495 - Sleep, Rhythms and Risk of Alzheimer's Disease N/A
Recruiting NCT06079853 - Nurse Suicide: Physiologic Sleep Health Promotion Trial N/A
Completed NCT05017974 - Research on Improving Sleep During Pregnancy N/A
Recruiting NCT05206747 - Ottawa Sunglasses at Night for Mania Study N/A
Enrolling by invitation NCT04253054 - Chinese Multi-provincial Cohort Study-Beijing Project
Completed NCT04513743 - Ultra Long-Term Sleep Monitoring Using UNEEG™ Medical 24/7 EEG™ SubQ N/A
Completed NCT03251274 - Bath Machine on Sleep Quality in Nursing Home N/A
Completed NCT04102345 - Lavender vs Zolpidem Sleep Quality During Diagnostic PSG Early Phase 1
Completed NCT03725943 - Comparison of Dreem to Clinical PSG for Sleep Monitoring in Healthy Adults N/A
Active, not recruiting NCT05062161 - Sleep Duration and Blood Pressure During Sleep N/A
Completed NCT04562181 - Consistency Evaluation of the qCON, qNOX Indices and Bispectral Index N/A
Completed NCT05102565 - A Dyadic Telehealth Program for Alzheimer's Patients/Caregivers N/A
Completed NCT05576844 - Ai Youmian (Love Better Sleep) for People Living With HIV N/A
Enrolling by invitation NCT04688099 - Synovial Fluid Sleep Study
Recruiting NCT04171245 - Prescribing Laughter for Sleep and Wellbeing in UAE University Students N/A
Completed NCT03758768 - The Effects of a Blue Monochromatic Light Intervention on Evening-type Individuals' Sleep and Circadian Rhythms N/A
Completed NCT03163498 - Evaluation of Sleep Pattern and Mood Profile in Hypertensive Patients
Completed NCT04093271 - Investigating the Efficacy of Rest-ZZZ Formula in Healthy Participants With Difficulty Falling Asleep or Staying a Sleep Phase 1
Completed NCT03673397 - The Acute Effect of Aerobic Exercise on Sleep in Patients With Depression N/A
Completed NCT04120363 - Trial of Testosterone Undecanoate for Optimizing Performance During Military Operations Phase 4